Free Trial
NYSE:CHE

Chemed (CHE) Stock Price, News & Analysis

Chemed logo
$580.52 -0.86 (-0.15%)
Closing price 04/17/2025 03:59 PM Eastern
Extended Trading
$582.02 +1.51 (+0.26%)
As of 07:50 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Chemed Stock (NYSE:CHE)

Key Stats

Today's Range
$576.36
$583.76
50-Day Range
$544.75
$619.47
52-Week Range
$512.12
$623.61
Volume
110,655 shs
Average Volume
97,566 shs
Market Capitalization
$8.48 billion
P/E Ratio
29.33
Dividend Yield
0.34%
Price Target
$667.00
Consensus Rating
Buy

Company Overview

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company was incorporated in 1970 and is headquartered in Cincinnati, Ohio.

Chemed Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
94th Percentile Overall Score

CHE MarketRank™: 

Chemed scored higher than 94% of companies evaluated by MarketBeat, and ranked 43rd out of 916 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Chemed has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Chemed has only been the subject of 1 research reports in the past 90 days.

  • Read more about Chemed's stock forecast and price target.
  • Earnings Growth

    Earnings for Chemed are expected to grow by 8.73% in the coming year, from $21.43 to $23.30 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Chemed is 29.33, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 21.40.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Chemed is 29.33, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 21.94.

  • Price to Earnings Growth Ratio

    Chemed has a PEG Ratio of 2.15. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Chemed has a P/B Ratio of 7.89. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Chemed's valuation and earnings.
  • Percentage of Shares Shorted

    1.64% of the float of Chemed has been sold short.
  • Short Interest Ratio / Days to Cover

    Chemed has a short interest ratio ("days to cover") of 2.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Chemed has recently decreased by 18.76%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Chemed has a dividend yield of 0.34%, which is in the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Chemed has been increasing its dividend for 16 years.

  • Dividend Coverage

    The dividend payout ratio of Chemed is 10.05%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, Chemed will have a dividend payout ratio of 8.58% next year. This indicates that Chemed will be able to sustain or increase its dividend.

  • Read more about Chemed's dividend.
  • Percentage of Shares Shorted

    1.64% of the float of Chemed has been sold short.
  • Short Interest Ratio / Days to Cover

    Chemed has a short interest ratio ("days to cover") of 2.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Chemed has recently decreased by 18.76%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Chemed has a news sentiment score of 1.38. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.59 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 20 news articles for Chemed this week, compared to 8 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Chemed insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,802,670.00 in company stock.

  • Percentage Held by Insiders

    Only 3.32% of the stock of Chemed is held by insiders.

  • Percentage Held by Institutions

    95.85% of the stock of Chemed is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Chemed's insider trading history.
Receive CHE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Chemed and its competitors with MarketBeat's FREE daily newsletter.

CHE Stock News Headlines

Chemed Co. (NYSE:CHE) CEO Sells $615,330.00 in Stock
[Action Required] Claim Your FREE IRS Loophole Guide
This shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the biggest "dollar reset" since 1971.
See More Headlines

CHE Stock Analysis - Frequently Asked Questions

Chemed's stock was trading at $529.80 on January 1st, 2025. Since then, CHE stock has increased by 9.6% and is now trading at $580.5150.
View the best growth stocks for 2025 here
.

Chemed Co. (NYSE:CHE) announced its quarterly earnings results on Tuesday, October, 29th. The company reported $5.64 earnings per share (EPS) for the quarter, missing the consensus estimate of $5.76 by $0.12. The firm's revenue was up 7.4% compared to the same quarter last year.
Read the conference call transcript
.

Top institutional investors of Chemed include GAMMA Investing LLC (1.14%), Rhumbline Advisers (0.39%), Fort Washington Investment Advisors Inc. OH (0.27%) and Janney Montgomery Scott LLC (0.07%). Insiders that own company stock include Kevin J Mcnamara, Spencer S Lee, David Patrick Williams, Nicholas Michael Westfall, Andrea R Lindell, Patrick P Grace, George J Walsh III, Michael D Witzeman and Brian C Judkins.
View institutional ownership trends
.

Shares of CHE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Chemed investors own include Humana (HUM), American Water Works (AWK), Waste Connections (WCN), Voyager Therapeutics (VYGR), The RMR Group (RMR), DiamondRock Hospitality (DRH) and AUO (AUOTY).

Company Calendar

Last Earnings
10/29/2024
Record date for 3/14 Dividend
2/24/2025
Ex-Dividend for 3/14 Dividend
2/24/2025
Dividend Payable
3/14/2025
Today
4/20/2025
Next Earnings (Estimated)
4/23/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Home health care services
Sub-Industry
Health Care Services
Current Symbol
NYSE:CHE
Employees
14,200
Year Founded
1970

Price Target and Rating

Average Stock Price Target
$667.00
High Stock Price Target
$667.00
Low Stock Price Target
$667.00
Potential Upside/Downside
+14.9%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Trailing P/E Ratio
29.33
Forward P/E Ratio
27.09
P/E Growth
2.15
Net Income
$272.51 million
Pretax Margin
16.61%

Debt

Sales & Book Value

Annual Sales
$2.43 billion
Cash Flow
$25.92 per share
Price / Cash Flow
22.40
Book Value
$73.55 per share
Price / Book
7.89

Miscellaneous

Free Float
14,550,000
Market Cap
$8.48 billion
Optionable
Optionable
Beta
0.49

Social Links

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (NYSE:CHE) was last updated on 4/21/2025 by MarketBeat.com Staff
From Our Partners